China SXT Pharmaceuticals
SXTC
SXTC
5 hedge funds and large institutions have $238K invested in China SXT Pharmaceuticals in 2021 Q2 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 2 reducing their positions, and 2 closing their positions.
Holders
5
Holders Change
-1
Holders Change %
-16.67%
% of All Funds
0.09%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
2
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
| 1 |
1
Squarepoint
New York
|
$39K |
Top Sellers
| 1 |
1
Goldman Sachs
New York
|
$0 |
| 2 |
2
Citadel Advisors
Miami,
Florida
|
$48K |
| 3 |
HF
3
HRT Financial
New York
|
$112K |
| 4 |
4
UBS Group
Zurich,
Switzerland
|
$0 |
| Name | Market Value | Shares |
Shares Change |
Shares Change % |
|
|---|---|---|---|---|---|
|
HF
1
HRT Financial
New York
| $112K | 77,901 | -17,599 | -18% |
|
|
2
Citadel Advisors
Miami,
Florida
| $48K | 33,053 | -20,365 | -38% |
|
|
3
Squarepoint
New York
| $39K | 26,997 | +26,997 | New |
|
4
Geode Capital Management
Boston,
Massachusetts
| $38K | 26,642 | – | – |
|
5
Royal Bank of Canada
Toronto,
Ontario, Canada
| $1K | 625 | – | – |
|
|
6
Goldman Sachs
New York
| – | – | -26,408 | Closed |
|
|
7
UBS Group
Zurich,
Switzerland
| – | – | -8,523 | Closed |
|
|
CFGS
8
Concourse Financial Group Securities
Birmingham,
Alabama
| – | – | – | – |
|